New Search

If you are not happy with the results below please do another search

113 search results for:

51

NCL provided oral testimony to the Center for Disease Control and Prevention’s Advisory Committee on Immunization Practices in support of new pneumococcal vaccine recommendations for adults 65 years of age and older

On June 22, 2022, NCL’s Health Policy Associate Milena Berhane provided oral testimony to the Center for Disease Control and Prevention’s Advisory Committee on Immunization Practices in support of new pneumococcal vaccine recommendations for adults 65 years of age and older.

52

NCL backs the Pregnant Workers Fairness Act to curtail workplace discrimination

The National Consumers League (NCL) believes it is imperative that the Pregnant Workers Fairness Act (H.R. 1065), introduced by Representative Jerrold Nadler (NY-10), is enacted by Congress. In the uphill battle for equity in the workplace, NCL views H.R. 1065 as essential to protecting pregnant workers against unjustly losing their jobs and ensuring they receive pregnancy and post-partum accommodations to stay healthy.

53

NCL Director of Health Policy testifies at Senate Judiciary Subcommittee on Competition Policy, Antitrust, and Consumer Rights on how consolidation in the marketplace harms consumers

On Wednesday, June 15, 2022, the National Consumers League’s Director of Health Policy Jeanette Contreras provided oral testimony to the Senate Judiciary Subcommittee on Competition Policy, Antitrust, and Consumer Rights on how consolidation in the marketplace harms consumers.

54

The National Consumers League applauds the FTC’s decision to investigate PBMs

NCL is deeply concerned by the lack of transparency and accountability surrounding pharmacy benefit managers (PBMs). The pervasive power of PBMs in the pharmaceutical industry has raised out-of-pocket costs for consumers and made it more difficult for them to receive essential medical treatment. NCL believes that the FTC’s investigation into PBMs represents a significant first step to addressing these issues.

55

National Consumers League supports the HELP Copays Act to make prescription drugs more affordable for consumers

The National Consumers League (NCL) is pleased to support the HELP Copays Act (H.R. 5801), introduced by Representatives Donald McEachin (VA-04) and Rodney Davis (IL-13). NCL stands with other aligned stakeholder groups, as part of the All Copays Count Coalition (ACCC), to protect patients from increased out-of-pocket medical costs and ensure that essential and life-saving drugs are readily accessible for all consumers.

56

The National Consumers League applauds the FDA for promptly responding to the infant formula shortage

NCL commends the Food and Drug Administration for taking strong and decisive actions to relieve the shortage in infant formula caused by the recall of a tainted product. We called upon the FDA to act and they did! We thank Commissioner Rob Califf for responding decisively to calls from Congress and affected families across the country.

57

2022 Script Your Future Medication Adherence Team Challenge Winners

Announcing the eleventh annual Script Your Future Medication Adherence Team Challenge winners, a competition designed to engage pharmacy students and faculty across the nation by encouraging teams to develop creative initiatives to raise public awareness about the importance of medication adherence, vaccine confidence, and safe drug disposal. This year’s winners are Wilkes University, Temple University, Western University, Northeast Ohio Medical University (NEOMED), University of Pittsburgh, and Touro University California.

58

NCL speaks out against the decision to overturn abortion rights

The National Consumers League (NCL) is gravely disappointed to learn, through a prematurely leaked Supreme Court decision, that the Supreme Court is likely to overturn the right to abortion in the United States. The leaked opinion will overturn the 1973 Roe v. Wade decision, which made access to abortions a federally protected right, and is a radical departure from current law, not even protecting women in the case of rape or incest.

60

NCL Briefing: measuring the 340B program’s impact on charitable care and operating profits for covered entities

Join the National Consumers League for a panel discussion with experts from Health Capital Group, the Community Oncology Alliance, and Johns Hopkins on this new white paper, which analyzes 340B’s impact on hospital profit margins and charitable care spending and attempts to quantify the amount of program benefits accruing to covered entities, contract pharmacies and patients.